SKIN.L Regulatory News (SKIN)

AIM share code: SKIN

7 February 2020

Integumen PLC

("Integumen" or "Company")

Integumen plc to present at The UK Investor Show

Integumen plc (AIM: SKIN) is delighted to announce that it will be participating in Britain's largest one day investor event, the Global Group UK Investor Show on 25th April at the QEII Centre in Westminster, London.

Gerard Brandon, CEO of Integumen will be speaking at 11:40am in room Slater and C-Level management, members of Rinocloud and Labskin, will be manning Stall 15 all day, so there will be an opportunity to meet the team and ask your questions face to face.

The UK Investor Show show features speakers including Mark Slater, Gervais Williams, Vin Murria, Graham Neary and Nigel Wray as well as presentations by c90 listed companies and is expected to attract in excess of 2,500 serious investors.

The event takes place on Saturday 25th April 2020 at the Queen Elizabeth II Conference Centre in Westminster, London SW1P 3EE. The team will be available from 8:30am until 5:30pm to discuss recent events for the Company as well as their strategy for accelerating growth.

FREE tickets can be secured today using discount code MeetTheTeam at checkout: https://www.ukinvestorshow.com/tickets/

More details of the conference can be found at www.ukinvestorshow.com

Gerard will also be presenting at the UK Investor City Forum 5:30pm Wednesday 26th February 2020

Location: Ashurst, London Fruit & Wool Exchange 1 Duval Square, London E1 6PW.

Contacts

About Integumen: www.integumen.com

Integumen is a vertically integrated product and services company for skin related diseases, treatments and therapies with four business units:

·; Labskin AI's technology platform incorporates artificial intelligence within clinical research for medical device, pharmaceuticals, cosmeceuticals and related life science test services. Labskin allows skincare, healthcare, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.

·; Rinodrive is a data aggregation, refining and AI analysis open-source eco-system designed to provide third-party service providers the ability to offer their clients valuable insights that support clinical, operational and financial decisions in healthcare services, third-level education, government departments and the financial sector.

·; Wound pHase is developing skin and wound care products using its proprietary wound dressing technology. Working in collaboration with CBD providers creating a CBD infused diabetic wound care product range.

·; Stoer-for-men skin products e-commerce division offers a range of skincare products derived from 5 natural super-ingredient plant extracts specifically for men to reduce the signs of ageing and is also used as a control for client testing within Labskin laboratories.

About RNS Reach announcements

RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.